
| Æ·ÅÆ | SCRSTANDARD | ¹©»õÖÜÆÚ | ÏÖ»õ |
|---|---|---|---|
| Ó¦ÓÃÁìÓò | Ò½ÁÆÎÀÉú,»¯¹¤,ÉúÎï²úÒµ,ÖÆÒ©/ÉúÎïÖÆÒ© |
¿¹½áºË²¡¡¢Âé·ç²¡Ò©ÎïÄÚ±êϵÁÐ
¿¹½áºË²¡¡¢Âé·ç²¡Ò©ÎïÄÚ±êϵÁÐ
| »õºÅ | ÖÐÎÄÃû | Ó¢ÎÄÃû |
| ¿¹½áºË²¡Ò©ÎïÄÚ±ê | ||
| °±»ùË®ÑîËá | ||
| SCBD-120022 | °Ú2±á3±Õ-5-°±»ùË®ÑîËá | [2H3]-5-Aminosalicylic acid |
| SCSI-405098 | °Ú2±á3±Õ-±·-ÒÒõ£»ù-4-°±»ùË®ÑîËá | [2H3]-N-Acetyl-4-aminosalicylic Acid |
| SCSI-300524 | °Ú13°ä6±Õ-±·-ÒÒõ£»ù-5-°±»ùË®ÑîËá | [13C6]-N-Acetyl-5-aminosalicylic acid |
| SCSI-511912 | °Ú13°ä6±Õ-±è-°±»ùË®ÑîËá | [13C6]-p-Aminosalicylic acid |
| ÒÒ°·¶¡´¼ | ||
| SCY-J-507420 | °Ú2±á4±Õ-ÒÒ°·¶¡´¼ | [2H4]-Ethambutol |
| SCSI-401651 | °Ú2±á4±Õ-ÒÒ°·¶¡´¼¶þÑÎ-ËáÑÎ | [2H4]-Ethambutol Dihydrochloride |
| SCSI-404699 | °Ú2±á4±Õ-(¸é,¸é)-ÒÒ°·¶¡´¼¶þÑÎ-ËáÑÎ | [2H4]-(R,R)-Ethambutol Dihydrochloride |
| SCSI-520146 | °Ú2±á4±Õ-(2³§,2'³§)-ÒÒ°·¶¡´¼ | [ethylene-2H4]-(2S,2'S)-Ethambutol |
| SCSI-520147 | °Ú2±á10±Õ-(2³§,2'³§)-ÒÒ°·¶¡´¼ | [1,1,1',1',2,2'-2H6; ethylene-2H4]-(2S,2'S)-Ethambutol |
| ßÁàº-õ£°· | ||
| SCCT-400657 | °Ú2±á3±Õ-ßÁàº-õ£°· | [2H3]-Pyrazinamide |
| SCSI-511631 | °Ú2±á3,15±·±Õ-ßÁàº-õ£°· | [2H3, 15N]-Pyrazinamide |
| SCSI-512656 | °Ú13°ä2,15±·2±Õ-ßÁàº-õ£°· | [13C2,15N2]-Pyrazinamide |
| ÒìÑÌ-ë | ||
| SCCT-400909 | °Ú2±á4±Õ-ÒìÑÌ-ë | [2H4]-Isoniazid |
| SCSI-402385 | °Ú2±á4±Õ-ÒÒõ£ÒìÑÌ-ë | [2H4]-Acetyl Isoniazid |
| Àû¸£-ƽ | ||
| SCSI-400834 | °Ú2±á3±Õ-Àû¸£-ƽ | [2H3]-Rifampicin |
| SCSI-510102 | °Ú2±á8±Õ-Àû¸£-ƽ | [2H8]-Rifampicin |
| SCSI-403084 | °Ú2±á8±Õ-±·-È¥¼×»ùÀû¸£-ƽ | [2H8]-N-Demethyl Rifampicin |
| ¿¹Âé·ç²¡Ò©ÎïÄÚ±ê | ||
| °±±½-í¿ | ||
| SCSI-402434 | °Ú2±á4±Õ-°±±½-í¿ | [2H4]-Dapsone |
| SCCT-101410 | °Ú2±á8±Õ-°±±½-í¿ | [2H8]-Dapsone |
| SCSI-400725 | °Ú2±á4±Õ-ôǰ·°±±½-í¿ | [2H4]-Dapsone Hydroxylamine |
| SCSI-511109 | °Ú2±á4±Õ-±·-ÒÒõ£°±±½-í¿ | [2H4]-N-Acetyl Dapsone |
| SCAH-200867 | °Ú13°ä12±Õ-°±±½-í¿ | [13C12]-Dapsone |
| ÂÈ·¨-ÆëÃ÷ | ||
| SCSI-510593 | °Ú2±á6±Õ-ÂÈ·¨-ÆëÃ÷ | [2H6]-Clofazimine |
| SCSI-510333 | °Ú2±á7±Õ-ÂÈ·¨-ÆëÃ÷ | [2H7]-Clofazimine |
³§°ä¸é³§°Õ´¡±·¶Ù´¡¸é¶ÙÊôÓÚÉϺ£Èü¿ÉÈñÆìϽø¿ÚÆ·ÅÆ£¬Îª¿ÆÑй¤×÷ÕßÌṩÓÅÖʲúÎïºÍÕæ³Ï·þÎñ¡£
³§°ä¸é³§°Õ´¡±·¶Ù´¡¸é¶ÙÆ·ÅÆ£¬²úÎïÖÖÀàÆëÈ«£¬Ö÷Òª°üÀ¨ÒÔϼ¸Àࣺ
¡ôÒ©ÎﻯºÏÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ô°±»ùËá¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï
¡ôÌÇÀ༰ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ôάÉúËØ¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï
¡ôÖ¬À༰ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ôÈâ¼î¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï
¡ôµ¨ÖËá¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ô¼¤ËØÀà¹Ì´¼À༰ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï
¡ôÖ²ÎïÌáÈ¡Îï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ô¾ÛºÏÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎ°üÀ¨GPC·Ö×ÓÁ¿±êÆ·£¬PEGÑÜÉúÎïµÈ£©
¡ô»·¾³¼ì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ô¹¤Òµ¼ì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï
¡ôÅ©²ÐÊ޲мì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ô±ê×¼ÈÜÒº¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎɫ¶È±êÒº, AAS, ICP, ICP-MS, ICµÈ±êÒº£©
¡ôʳƷ¼ì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï ¡ô»ùÖʼì²â±êÎï¼°ÆäÎȶ¨Í¬Î»Ëرê¼ÇÎï
ÉÏһƪ : ³§°ä³§±õ-510874¿¹¼ÄÉú³æ²¡Ò©ÏµÁÐ
ÏÂһƪ : Âé¶¹9191¾«Æ·¹ú²ú